IDO1 and neoplasm: For instance, the interaction between CD80/86 and CTLA-4 on human DCs and CD4+ T cells has been shown to trigger the expression of indoleamine 2,3-dioxygenase (IDO) in DCs, an enzyme that suppresses T cell proliferation and induces tumor immunosuppression [33].